These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37277322)

  • 1. Cost-effectiveness of neuromuscular electrical stimulation for the treatment of mild obstructive sleep apnea: an exploratory analysis.
    Liu S; Cao KN; Garner AM; Punjabi NM; Pietzsch JB
    Int J Technol Assess Health Care; 2023 Jun; 39(1):e32. PubMed ID: 37277322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea-hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure.
    Sharples L; Glover M; Clutterbuck-James A; Bennett M; Jordan J; Chadwick R; Pittman M; East C; Cameron M; Davies M; Oscroft N; Smith I; Morrell M; Fox-Rushby J; Quinnell T
    Health Technol Assess; 2014 Oct; 18(67):1-296. PubMed ID: 25359435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea.
    Pietzsch JB; Garner A; Cipriano LE; Linehan JH
    Sleep; 2011 Jun; 34(6):695-709. PubMed ID: 21629357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical- and Cost-Effectiveness of a Mandibular Advancement Device Versus Continuous Positive Airway Pressure in Moderate Obstructive Sleep Apnea.
    de Vries GE; Hoekema A; Vermeulen KM; Claessen JQPJ; Jacobs W; van der Maten J; van der Hoeven JH; Stegenga B; Kerstjens HAM; Wijkstra PJ
    J Clin Sleep Med; 2019 Oct; 15(10):1477-1485. PubMed ID: 31596213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COST-EFFECTIVENESS OF TREATMENTS FOR MILD-TO-MODERATE OBSTRUCTIVE SLEEP APNEA IN FRANCE.
    Poullié AI; Cognet M; Gauthier A; Clementz M; Druais S; Späth HM; Perrier L; Scemama O; Pichon CR; Harousseau JL
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):37-45. PubMed ID: 26956455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICT.
    McMillan A; Bratton DJ; Faria R; Laskawiec-Szkonter M; Griffin S; Davies RJ; Nunn AJ; Stradling JR; Riha RL; Morrell MJ
    Health Technol Assess; 2015 Jun; 19(40):1-188. PubMed ID: 26063688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis.
    McDaid C; Griffin S; Weatherly H; Durée K; van der Burgt M; van Hout S; Akers J; Davies RJ; Sculpher M; Westwood M
    Health Technol Assess; 2009 Jan; 13(4):iii-iv, xi-xiv, 1-119, 143-274. PubMed ID: 19103134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Utility Analysis of Continuous Positive Airway Pressure Therapy Compared With Usual Care for Obstructive Sleep Apnea in the Public Health System in Brazil.
    Pachito DV; Eckeli AL; Drager LF
    Value Health Reg Issues; 2024 Mar; 40():81-88. PubMed ID: 38056224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Cost-Effectiveness of Upper Airway Stimulation for the Treatment of Obstructive Sleep Apnea: A Model-Based Projection Based on the STAR Trial.
    Pietzsch JB; Liu S; Garner AM; Kezirian EJ; Strollo PJ
    Sleep; 2015 May; 38(5):735-44. PubMed ID: 25348126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome.
    Weatherly HL; Griffin SC; Mc Daid C; Durée KH; Davies RJ; Stradling JR; Westwood ME; Sculpher MJ
    Int J Technol Assess Health Care; 2009 Jan; 25(1):26-34. PubMed ID: 19126248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cost-Effectiveness Analysis of Surgery for Middle-Aged Men with Severe Obstructive Sleep Apnea Intolerant of CPAP.
    Tan KB; Toh ST; Guilleminault C; Holty JE
    J Clin Sleep Med; 2015 Apr; 11(5):525-35. PubMed ID: 25700871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of oral appliances in the treatment of obstructive sleep apnoea-hypopnoea.
    Sadatsafavi M; Marra CA; Ayas NT; Stradling J; Fleetham J
    Sleep Breath; 2009 Aug; 13(3):241-52. PubMed ID: 19229577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-utility and budget impact analysis of CPAP therapy compared to no treatment in the management of moderate to severe obstructive sleep apnea in Colombia from a third-party payer perspective.
    Robles A; Gil-Rojas Y; Amaya D; Hernández F; Escobar-Cordoba F; Venegas M; Amado S; Restrepo-Gualteros S; Echeverry J; Marín F; Zabala S; Bazurto-Zapata MA; Deger M
    Expert Rev Pharmacoecon Outcomes Res; 2023 Apr; 23(4):399-407. PubMed ID: 36852713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transoral awake state neuromuscular electrical stimulation therapy for mild obstructive sleep apnea.
    Nokes B; Baptista PM; de Apodaca PMR; Carrasco-Llatas M; Fernandez S; Kotecha B; Wong PY; Zhang H; Hassaan A; Malhotra A
    Sleep Breath; 2023 May; 27(2):527-534. PubMed ID: 35624401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of continuous positive airway pressure therapy in patients with obstructive sleep apnea-hypopnea in British Columbia.
    Tan MC; Ayas NT; Mulgrew A; Cortes L; FitzGerald JM; Fleetham JA; Schulzer M; Ryan CF; Ghaeli R; Cooper P; Marra CA
    Can Respir J; 2008 Apr; 15(3):159-65. PubMed ID: 18437259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives.
    Streatfeild J; Hillman D; Adams R; Mitchell S; Pezzullo L
    Sleep; 2019 Dec; 42(12):. PubMed ID: 31403163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K.
    Guest JF; Panca M; Sladkevicius E; Taheri S; Stradling J
    Diabetes Care; 2014; 37(5):1263-71. PubMed ID: 24705611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Economic Benefits of Upper Airway Stimulation for Obstructive Sleep Apnea in a European Setting.
    Pietzsch JB; Richter AK; Randerath W; Steffen A; Liu S; Geisler BP; Wasem J; Biermann-Stallwitz J
    Respiration; 2019; 98(1):38-47. PubMed ID: 30923287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral appliance versus continuous positive airway pressure in obstructive sleep apnea syndrome: a 2-year follow-up.
    Doff MH; Hoekema A; Wijkstra PJ; van der Hoeven JH; Huddleston Slater JJ; de Bont LG; Stegenga B
    Sleep; 2013 Sep; 36(9):1289-96. PubMed ID: 23997361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea.
    Ayas NT; FitzGerald JM; Fleetham JA; White DP; Schulzer M; Ryan CF; Ghaeli R; Mercer GW; Cooper P; Tan MC; Marra CA
    Arch Intern Med; 2006 May; 166(9):977-84. PubMed ID: 16682570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.